Kerbside

Arvind DSIJ / 25 Jun 2026 / Categories: DSIJ_Magazine_Web, DSIJMagazine_App, Informed Intelligence, Kerbside, Regular Columns

Kerbside

The recommendations provided in this column are taken from various market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Therefore we advise readers to use their own discretion before investing in these recommendation

CHEMISTRY OF GROWTH [EasyDNNnews:PaidContentStart]

Vishnu Chemicals
BSE Code: 516072
CMP: ₹631.20 

Vishnu Chemicals is not just mixing chemicals; it is building a stronger formula for growth. The company clocked its highest-ever annual performance in FY26, crossing the ₹1,600 crore revenue milestone, with operating revenue at ₹1,609.7 crore, EBITDA at ₹252.4 crore and PAT at ₹142.2 crore. Q4 was equally sharp, with revenue up 14.7 per cent YoY and EBITDA jumping 19.7 per cent, showing improving operating momentum. And here’s the real spark: its backward integration acquisition is completed, integration is underway and phased production is expected from H2, which could strengthen raw material security. Add to this the commercialisation of strontium chemicals, positive customer approvals, better FY27 utilisation and new high-value speciality chemicals for pharma, agrochemicals and electronics—Vishnu may have the right chemistry for a near-term rerating. 

MEDANTA’S GROWTH DOSE 

Global Health
BSE Code: 543654
CMP: ₹1,288.50 

Global Health, operator of the Medanta hospital chain, is not just treating patients—it is scaling a premium healthcare engine. Q4FY26 packed a strong punch, with revenue, EBITDA and PAT rising 25 per cent, 9 per cent and 42 per cent YoY, helped by ARPOB moving to Rs 66,687 per day. The near-term kicker is capacity. Medanta added 623 beds in FY26, including Noida’s 382-bed facility with around 100 ICU beds and 14 OTs, while Patna and Ranchi also expanded. Noida’s losses dragged margins in FY26, but ramp-up in new units, better utilisation and a rising international patient mix could change the earnings prescription. With murmurs of expectations of 15/24/18 per cent revenue/ EBITDA/PAT CAGR over FY26-28, the stock has clear rerating medicine. 


HEATING UP THE Order Book 

Thermax
BSE Code: 500411
CMP: ₹4,862.10 

Thermax is not just an energy and environment solutions company—it is a clean-tech engineering powerhouse with installations across 90+ countries and 18 manufacturing locations. Q4FY26 brought the real spark: order booking jumped 112 per cent YoY to Rs 4,490 crore, while order balance rose 27 per cent to Rs 13,604 crore. The biggest trigger is the Rs 1,600 crore-plus boiler package order for a 1x800 MW ultra-supercritical thermal power plant in Central India. Add to that rising traction in data centre cooling, green steam, waste-to-energy, CBG plants and biomass solutions, and Thermax looks well placed to ride India’s industrial capex and energy transition wave. With PAT up 18 per cent in Q4, the stock may be warming up. 

ON THE RADAR 

Bharat Electronics
BSE Code: 500049
CMP: ₹431.45 

Bharat Electronics Ltd. is not just another Defence PSU—it is a key technology backbone of India’s air defence ecosystem. The near-term buzz around BEL comes from insider sources indicating that the UAE is in fast-moving talks with India for key defence systems, including Akashteer, the automated air-defence command-and control network jointly developed by BEL with the Indian Army. Why BEL? Akashteer links sensors, radars and weapon systems to counter aerial threats, making it highly relevant after the recent Middle East conflict. With global interest rising in India-made defence platforms and India’s defence exports crossing USD 4 billion in FY26, any progress on overseas Akashteer orders could act as a strong sentiment booster for BEL. 

(Closing price as of June 22, 2026)

[EasyDNNnews:PaidContentEnd] [EasyDNNnews:UnPaidContentStart]

[EasyDNNnews:UnPaidContentEnd]